Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis.
about
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaClinical implications of cancer stem cell biology in hepatocellular carcinoma.Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities.Heterogeneity of The CD90(+) Population in Different Stages of Hepatocarcinogenesis.Gene expression profiling of histiocytic sarcomas in a canine model: the predisposed flatcoated retriever dogThe expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro studyExpression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA.miR-589-5p inhibits MAP3K8 and suppresses CD90(+) cancer stem cells in hepatocellular carcinoma.Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma.Extracellular vesicles-mediated noncoding RNAs transfer in cancer.The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.Cervical cancer stem cells: opportunities and challenges.Multiple roles of CD90 in cancer.Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment.Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.Cancer stem cell marker glycosylation: Nature, function and significance.Cancer Stem Cells in Hepatocellular Carcinoma.Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA).A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells.Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma.CD90 promotes cell migration, viability and sphere‑forming ability of hepatocellular carcinoma cells.Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC.EpCAM-targeted therapy for human hepatocellular carcinoma.Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma.
P2860
Q26773251-DF8E88F7-8045-4636-9C3B-F38657367D48Q34357073-1D236526-157B-47EF-9D6B-B453A17F9C87Q34644926-3304F3EA-C157-4C93-8287-4D7AA0ABF070Q34845447-291FEC6C-0767-4011-BE37-47BC87583684Q34926467-D982B56B-1677-495E-8DB7-493DE5177593Q35014932-4140CF81-7DF2-4BF7-8A00-C372D8A7D36FQ35745018-E7DFF5E7-9F3B-4504-85DF-292D5EA5A031Q35954464-A8BE26E8-C7D2-4379-88FD-DAD373DF3111Q37410466-61F42A6C-DA39-4035-A3BA-DFB75500A1FDQ37582429-146E517D-0214-4D49-A3F6-688C38A09A01Q37663393-1B729382-ED1C-4372-9E15-15674A0674F8Q38155666-351F85F4-8CE7-4CF5-B211-BA3EF236524DQ38309029-EF2C5136-3BAF-4370-8DEF-9B6C48977E67Q38805813-AB43DA3A-D0BB-4632-846F-EF8E2B32A397Q39177087-E4C9A172-826B-4645-9F8C-B5FFA5B3F0DFQ39240497-7BF3FC81-8F3A-434A-9CC8-B3397B8D5F57Q39380552-7F98890C-1F02-4B8A-98FF-76DEAC365726Q39393146-9596AC31-BA6B-4E98-8BD1-846F5D0A242EQ40648635-F06C4747-381D-44A4-86BF-762D15E5A010Q42049959-80D18763-046A-4D70-8F54-E105EB953AFCQ44320637-82B0B259-514C-4DE7-85C1-0827B3640BA7Q47292629-FB8DD66F-1B13-4635-B28D-483EAD51BC57Q50053655-799F9803-16D2-4C64-B92D-88E889C3A510Q54395760-3AB529F9-781C-4A36-B96D-F18761CCE64FQ54459170-378AF15B-0E50-45FC-AEB5-29129879ABBD
P2860
Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Overexpression of Thy1/CD90 in ...... infection and poor prognosis.
@en
Overexpression of Thy1/CD90 in ...... infection and poor prognosis.
@nl
type
label
Overexpression of Thy1/CD90 in ...... infection and poor prognosis.
@en
Overexpression of Thy1/CD90 in ...... infection and poor prognosis.
@nl
prefLabel
Overexpression of Thy1/CD90 in ...... infection and poor prognosis.
@en
Overexpression of Thy1/CD90 in ...... infection and poor prognosis.
@nl
P2093
P1433
P1476
Overexpression of Thy1/CD90 in ...... infection and poor prognosis.
@en
P2093
Jan-Gowth Chang
Jeffrey J P Tsai
Jeng-Wei Lu
Kun-Tu Yeh
Rong-Ming Chen
Rouh-Mei Hu
P304
P356
10.1016/J.ACTHIS.2011.01.001
P577
2011-01-26T00:00:00Z